Nectar Lifesciences CGST Writ Petition Punjab High Court

• Nectar Lifesciences discloses CGST Commissioner's civil writ petition challenging a favourable appellate order dated May 27, 2025.
• Contingent financial exposure totals up to ₹95.56 crore (₹89.32 crore dropped demand + ₹6.24 crore remanded demand) if writ is allowed in full.
• Matter is listed for hearing before the Hon'ble High Court of Punjab and Haryana on April 28, 2026; company strongly contests the petition.
• Disclosure filed under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular dated January 30, 2026.